New vaccines may address need to protect newborns in the developing world

PHILADELPHIA -- In a new research study, two prototype oral vaccines have both been shown capable of inducing protection against a dangerous virus in newborn mice. If the new vaccines are able to do the same for human newborns, they might be able to address an important window of immunological vulnerability in the lives of infant children. Particularly in the developing world, where the threat of infectious diseases is generally greater than in the developed world, many lives might be saved with vaccines of this type.

The vaccines are based on human and chimpanzee adenoviruses that have been altered in the laboratory so that they are unable to replicate. In the current proof-of-principle study, the viruses were engineered to incorporate a gene from the rabies virus. Following oral administration of the vaccine, newborn mice developed antibodies that protected them from subsequent exposure to the rabies virus. By extension, the researchers say, the same vaccine strategy might also prove effective against other viral diseases, such as measles, viral respiratory infections, and viral diarrhea. A report on the study findings appears in the October 15 issue of the Journal of Immunology.

The potential significance of the new study lies in the effectiveness of the prototype vaccines in newborns. Although newborns are protected from most common viral infections immediately after birth by antibodies received from their mothers, these antibodies decline in the first weeks and months of life as the fledgling immune system grows in its capacity to generate its own antibody protections against viruses. Between the waning of maternal-antibody protection and the development of a fully functional immune system in the infant, a period of relatively poor defense against disease for infants is frequently seen. This is partly because the infant immune system is not yet sufficiently developed, but also because the maternal antibodies, while protecting the infant from inf

Contact: Franklin Hoke
The Wistar Institute

Page: 1 2 3

Related biology news :

1. Inadequate vaccines can help breed more vicious malaria strains
2. Researcher issues caution on live virus vaccines
3. Scientists learn how adjuvant makes vaccines effective
4. Thimerosal, found in childhood vaccines, can increase the risk of autism-like damage in mice
5. Botulinum toxin structure offers clues for vaccines/treatments
6. Gates Foundation commits $82.9 million to develop new tuberculosis vaccines
7. A link between thimerosal and the brain: Can vaccines affect central nervous system function?
8. WSU scientist part of study seeking vaccines to combat potential bioterrorist attack
9. Immune cells may help deliver cancer vaccines for children
10. Microgel polymer beads may provide general vehicle for vaccines, gene therapy
11. Bacterial viruses make cheap easy vaccines

Post Your Comments:

(Date:7/2/2020)... (PRWEB) , ... July 01, 2020 , ... ... presented its phase 1a findings of Neihulizumab, a biologic for the treatment of ... June 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the fall ... Care Testing solutions (POCT). Check local listings for more info. , Today, the majority ... are shipped to labs throughout the country. Results are then available several days later. ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... pleased to announce the next event in a series of TOPIQ webinars, which ... TOPIQ series of webinars was developed in response to social distancing measures that ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... Diversified Technologies, Inc. has introduced a full ... drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... push-pull configuration; yielding fast fall time for a capacitive load. These all solid-state ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... today announced the release of its signature product called Beacon - a ... and other field medical professionals. , Beacon helps MSLs streamline communication ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a leading ... food industries, is pleased to announce that Charles Galea has joined its clinical ... Charles is an accomplished and results-driven sales executive with over 10 years of ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in Mexico ... patient's condition, treatment may be offered IV, intrathecal or with a combination. , A ... and the incidence continues to increase as individuals live longer. There is no cure, ...
Breaking Biology Technology:
Cached News: